Shalby Limited has informed the Exchange about General Updates - credit of equity shares by subsidiary company on Rights Issue basis to the company
SHALBY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shalby Limited's subsidiary, PK Healthcare Private Limited (PKHPL), has allotted 5,96,01,950 equity shares of face value Rs. 10 each to Shalby at Rs. 10 per share, totalling Rs. 59.60 crore, on a rights issue basis. The rights issue was offered in the ratio of 1 new share for every 2 existing shares held as on January 24, 2026, and Shalby subscribed to its full entitlement. As a result, Shalby's stake in PKHPL has increased from 87.26% to 91.13%. The funds raised by PKHPL will be used for repayment of debt, working capital needs, and general corporate purposes. PKHPL, which Shalby acquired in January 2024 to expand into the Delhi/NCR region, reported turnover of Rs. 91.19 crore in FY25, up from Rs. 87.13 crore in FY24.
This is a routine capital infusion into Shalby's subsidiary using rights issue proceeds, strengthening the parent's ownership and providing PKHPL with funds to reduce debt and support operations. It is a within-group restructuring and should have minimal direct impact on Shalby's listed share price, though it modestly consolidates the parent's control over the growing NCR healthcare business.